Minimal Residual Disease–Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing. (14th June 2022) - Pokorna, Petra; Lakka Klement, Giannoula; Vasikova, Alzbeta; Kanderova, Veronika; Jezova, Marta; Noskova, Kristyna; Mudry, Peter; Kyr, Michal; Merta, Tomas; Bajciova, Viera; Krenova, Zdenka; Palova, Hana; et al.